After a detailed assessment of indicators at different levels, it can be concluded that oral FUC can mitigate visceral hypersensitivity through modulating depression-related hormones, 5-HT metabolism, expression of 5-HT3R, and the gut microbiota profile. This evidence concerns the gene HTR3A and depressive disorder.